small sized icon representing the Cardiovascular area of interest
Cardiovascular
GME:X Logo
GME:X
medium sized icon representing the Diabetes Care area of interest
Diabetes Care
small sized icon representing the Radiology area of interest
Radiology
small sized icon representing the Oncology area of interest
Oncology
small sized icon representing the Ophthalmology area of interest
Ophthalmology
small sized icon representing the Women's Health area of interest
Women's Health
medium sized icon representing the Nephrology area of interest
Nephrology
Bayer MedLearnEducate, Innovate & Heal
Podcast

Dr. Javed Butler: Vericiguat & WHF

Dr. Javed Butler emphasizes the urgent need to optimize medical therapy, including vericiguat, in patients with worsening heart failure. He highlights the extremely high mortality risk within the first year after hospitalization, with the greatest risk occurring in the first six months. Early intervention is crucial to prevent disease progression, end-organ damage, and transition to advanced heart failure, which often leads to limited treatment options such as LVAD, transplants, or palliative care.

Our speakers

  • MD, MPH, MBA, Baylor Scott and White Health.

    Dr. Javed Butler is a prominent figure in cardiovascular medicine, especially known for his work on heart failure. Based in Dallas, Texas, he holds leadership positions at Baylor Scott & White, including the Maxwell A. and Gayle H. Clampitt Endowed Chair, president, and chief research executive at the Research Institute, and senior vice president at the Health system. His expertise is recognized by his fellowships in several prestigious organizations, such as the Heart Failure Society of America, the European Society of Cardiology, the American College of Cardiology, and the American Heart Association.

    • Dr. Javed Butler
      MD, MPH, MBA, Baylor Scott and White Health.
Related content
Dr Javed Butler: NT-Pro BNP Interpretation
PP-VER-IN-0252-1, September 2024
Dr Javed Butler: Worsening Heart Failure
PP-VER-IN-0202-1, September 2024
Dr Javed Butler: Vericiguat in Heart Failure
PP-VER-IN-0231-1, September 2024